ESPR

Esperion Therapeutics Stock Price

51.28
0.46 (0.91%)
Upgrade to Real-Time
Regular Market
51.28
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Esperion Therapeutics Inc ESPR NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.46 0.91% 51.28 49.87 51.60 50.40 50.82 15:29:07
Bid Price Ask Price Spread Spread % News
51.24 51.27 0.03 0.06% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
4,758 291,232 $ 50.96 $ 14,841,806 677,082 24.82 - 79.989
Last Trade Time Type Quantity Stock Price Currency
15:29:15 60 $ 51.26 USD

Esperion Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.42B 27.62M 23.71M $ 148.36M $ - -3.75 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Esperion Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ESPR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week47.6453.587547.1151.10638,5263.647.64%
1 Month47.4953.587541.9246.46658,4143.797.98%
3 Months36.2853.587533.79543.79666,16115.0041.35%
6 Months61.4579.98924.8247.43775,218-10.17-16.55%
1 Year47.0379.98924.8245.90597,3654.259.04%
3 Years47.4082.6824.8248.61663,0213.888.19%
5 Years86.85100.989.4041.54718,237-35.57-40.96%

Esperion Therapeutics Description

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm has Business of researching, developing and commercializing therapies for the treatment of patients with the elevated LDL-C operating segment.


Your Recent History
NASDAQ
ESPR
Esperion T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.